• EVMPs for Extrahepatic mRNA Delivery

  2026-09-07

  The reference study presents a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) that delivers mRNA beyond the liver by combining engineered peptides with tunable phospholipid envelopes. Its strongest evidence is lung and spleen targeting, including substantial transfection of lung endothelial and immune cells, while repeated-dose and biosafety results support further evaluation of the platform.

• Diuron: Mechanism, Toxicology & Research Use

  2026-09-07

  Diuron, also called 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a chlorophenyl urea herbicide and photosynthesis inhibitor. Recent network toxicology and cell experiments connect Diuron exposure with JAK2/STAT1 activation and acute kidney injury mechanisms, while product specifications support controlled laboratory use.

• SN-38: From TOP1 Inhibition to Translational Strategy

  2026-09-05

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a mechanistically defined benchmark for studying topoisomerase I inhibition, replication-associated damage, cell-cycle arrest, apoptosis, and the FUBP1/FUSE regulatory axis in cancer models.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-04

  A scenario-driven guide to selecting, running, and interpreting the Annexin V-FITC/PI Apoptosis Assay Kit, with practical recommendations for flow cytometry apoptosis detection and microscopy. SKU K2003 supports rapid two-marker discrimination of viable, early apoptotic, late apoptotic, and membrane-compromised cells.

• Neticonazole Hydrochloride: Dual-Action Profile

  2026-09-04

  Neticonazole Hydrochloride is an imidazole antifungal with reported activity against fungal cell membrane synthesis and emerging colorectal cancer research applications. The product dossier describes topical antifungal use and a separate animal-model oncology signal, while the cited nanomedicine study provides delivery context rather than direct evidence for neticonazole.

• PPT: Selective ERα Agonist for Research

  2026-09-03

  PPT, or Propyl Pyrazole Triol, is a potent and selective ERα agonist for separating estrogen receptor alpha signaling from ERβ activity. Product data report approximately 410-fold ERα selectivity, cellular ERα-mediated gene-expression effects, and activity in a uterotrophic assay.

• BMX-IN-1 Workflows for BMX Kinase Research

  2026-09-03

  Build mechanism-focused assays around BMX-IN-1 to connect covalent BMX inhibition with cell-cycle control, apoptosis induction, and lysosomal acidification. The workflow also shows how to adapt a cancer-oriented BMX kinase inhibitor for carefully controlled host-pathogen studies without overstating compound-specific evidence.

• TAK-715: p38 MAPK Inhibitor Workflow

  2026-09-02

  TAK-715 combines nanomolar p38α activity with a practical workflow for dissecting cytokine responses, inflammatory signaling, and rheumatoid arthritis research models. This guide connects concentration planning, time-resolved phospho-assays, and the latest structural insight into p38α dephosphorylation without assuming that every p38 inhibitor has the same mechanism.

• ML385: Practical NRF2 Inhibitor Workflows

  2026-09-02

  ML385 provides a selective way to test whether NRF2 activity drives antioxidant defense, ferroptosis resistance, inflammation, or chemotherapy response. This workflow-focused guide covers assay design, concentration planning, mechanistic controls, and troubleshooting across cancer and oxidative stress models.

• Z-VEID-FMK: Caspase-6 Inhibition in Cell Assays

  2026-09-01

  This scenario-driven guide explains how Z-VEID-FMK, SKU A1923, can help researchers separate caspase-6-dependent apoptosis from nonspecific changes in cell viability. It covers assay design, solvent controls, protocol parameters, data interpretation, and practical vendor-selection criteria for biomedical workflows.

• Se-Methylselenocysteine Rewires NRF2 Stress in PDAC

  2026-09-01

  A 2026 study shows that se-methylselenocysteine produces phenotype-dependent NRF2 and ATF4 stress responses in pancreatic ductal adenocarcinoma cells. Its findings connect KYAT1-dependent metabolic activation with redox remodeling, lipid peroxidation, and ferroptosis-associated processes, while identifying low KYAT1 expression as a potential resistance determinant.

• Sodium Salicylate for PDAC Stromal Research

  2026-08-31

  A translational perspective on using sodium salicylate as an NF-κB inhibitor and mechanistic pathway probe in pancreatic cancer stromal biology, inspired by a sequential-release nanomedicine study.

• Artemisinin, Nrf2, and Ferroptosis in Diabetic Cognition

  2026-08-31

  Wang et al. show that artemisinin improves learning and memory in streptozotocin-induced T2DM mice while suppressing hippocampal CA1 neuronal ferroptosis. Pharmacological blockade of Nrf2 with ML385 and induction of ferroptosis with erastin weakened these effects, supporting an Nrf2–antioxidant defense mechanism that links oxidative stress to diabetic cognitive decline.

• Golgi-Tracker Green: Live-Cell Workflow Guide

  2026-08-30

  Golgi-Tracker Green enables photostable, selective visualization of Golgi membranes in living cells, supporting organelle morphology, lipid trafficking, and sphingolipid studies. This guide translates its ceramide-based chemistry into practical labeling, imaging, troubleshooting, and oncology assay workflows while clearly defining its fixed-cell limitations.

• EZ Cap™ Cy5 EGFP mRNA: Two-Channel Assay

  2026-08-29

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables simultaneous measurement of mRNA uptake and EGFP translation. This guide presents a compartment-aware assay strategy for distinguishing delivery, intracellular persistence, and functional expression in nanoparticle and transfection studies.

8145 records 1/543 page Next 12345 下5页 Last page